Cabotegravir + Rilpivirine
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Cabotegravir
cabotegravir - Rilpivirine
rilpivirine
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| CabenuvaAUCAUS | 600 mg / 900 mg / 200 mg / 300 mg | VIIV HEALTHCARE ULC |
| cabotegravir + rilpivirineAU | 600 mg / 900 mg | ViiV Healthcare Pty Ltd |
| CABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vialsAU | 600 mg / 900 mg / 400 mg | ViiV Healthcare Pty Ltd |
Same combination in other markets
No product with this combination is recorded in the other covered markets yet.
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.